Revance Therapeutics, Inc.: SC 13G/A filed Feb 14, 2024

Form type

SC 13G/A

Filing date

Feb 14, 2024

Accession number

0001306923-24-000006

Filer

Revance Therapeutics, Inc. (CIK 1479290)